Literature DB >> 11074924

Successful treatment of hepatitis C in sickle-cell disease.

M W Swaim, S Agarwal, W F Rosse.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11074924     DOI： 10.7326/0003-4819-133-9-200011070-00033

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Safety of pegylated interferon and ribavirin therapy for chronic hepatitis C in patients with sickle cell anemia.

Authors:  Hussain Issa
Journal:  World J Hepatol       Date:  2010-05-27

2.  Acute hepatic sequestration in sickle cell disease.

Authors:  William E Norris
Journal:  J Natl Med Assoc       Date:  2004-09       Impact factor: 1.798

Review 3.  HCV in sickle cell disease.

Authors:  Mohamed Hassan; Syed Hasan; Oswaldo Castro; Samuel Giday; Alpha Banks; Duane Smoot
Journal:  J Natl Med Assoc       Date:  2003-09       Impact factor: 1.798

4.  Peg-interfon alpha-2a and low-dose ribavirin for treatment of hepatitis C virus infection in patients with sickle-cell anemia in Saudi Arabia.

Authors:  Adnan Agha; Rafaat Chakik; Mamdouh M Abdulhadi Ali; Dib Alsaudi; Giorgio Sammito; Edoardo Giovanni Giannini
Journal:  Ann Saudi Med       Date:  2013 Nov-Dec       Impact factor: 1.526

Review 5.  Hepatobiliary Manifestations of Sickle Cell Anemia.

Authors:  Hussain Issa; Ahmed H Al-Salem
Journal:  Gastroenterology Res       Date:  2010-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.